HappeningToo topic
Doxazosin Mesylate reports
Browse community reports connected to Doxazosin Mesylate. These reports can show that other people are describing similar experiences, but they do not prove that Doxazosin Mesylate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
39 problems
Abdominal Discomfort while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and abdominal discomfort appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and abdominal pain upper appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and abdominal pain appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and anxiety appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and back pain appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and chest discomfort appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and constipation appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and cough appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and decreased appetite appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and dehydration appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and diarrhea appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and dizziness appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and dyspepsia appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and excessive sweating appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and fatigue appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and feeling abnormal appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and headache appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and hypotension appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and insomnia appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and itching appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and malaise appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and muscle spasms appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and muscular weakness appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and myalgia appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and nausea appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and pain appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and palpitations appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and peripheral swelling appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and rash appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and shortness of breath appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and skin redness appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and sleepiness appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and tingling or pins and needles appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and tremor appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and vision blurred appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and vomiting appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and weakness appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and weight decreased appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Doxazosin Mesylate
FDA FAERS contains adverse-event reports in which Doxazosin Mesylate and weight increased appear together. This does not establish that Doxazosin Mesylate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →